MXPA05008221A - Antigenos recombinantes del virus de la hepatitis a obtenidos en celulas vegetales. - Google Patents

Antigenos recombinantes del virus de la hepatitis a obtenidos en celulas vegetales.

Info

Publication number
MXPA05008221A
MXPA05008221A MXPA05008221A MXPA05008221A MXPA05008221A MX PA05008221 A MXPA05008221 A MX PA05008221A MX PA05008221 A MXPA05008221 A MX PA05008221A MX PA05008221 A MXPA05008221 A MX PA05008221A MX PA05008221 A MXPA05008221 A MX PA05008221A
Authority
MX
Mexico
Prior art keywords
plant cells
virus antigens
antigens obtained
hepatitis
recombinant hepatitis
Prior art date
Application number
MXPA05008221A
Other languages
English (en)
Spanish (es)
Inventor
Lay Licel Rodriguez
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Publication of MXPA05008221A publication Critical patent/MXPA05008221A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/04Fusion polypeptide containing a localisation/targetting motif containing an ER retention signal such as a C-terminal HDEL motif
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32411Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32422New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
MXPA05008221A 2003-01-31 2003-12-19 Antigenos recombinantes del virus de la hepatitis a obtenidos en celulas vegetales. MXPA05008221A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20030031A CU23202A1 (es) 2003-01-31 2003-01-31 ANTIGENOS RECOMBINANTES DEL VIRUS DE LA HEPATITIS A OBTENIDOS EN CéLULAS VEGETALES
PCT/CU2003/000017 WO2004067747A1 (es) 2003-01-31 2003-12-19 Antigenos recombinantes del virus de la hepatitis a obtenidos en celulas vegetales

Publications (1)

Publication Number Publication Date
MXPA05008221A true MXPA05008221A (es) 2005-10-05

Family

ID=40091669

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05008221A MXPA05008221A (es) 2003-01-31 2003-12-19 Antigenos recombinantes del virus de la hepatitis a obtenidos en celulas vegetales.

Country Status (14)

Country Link
US (1) US20060147469A1 (ja)
EP (1) EP1589111A1 (ja)
JP (1) JP2006514078A (ja)
KR (1) KR20050100365A (ja)
CN (1) CN1745174A (ja)
AR (1) AR042960A1 (ja)
AU (1) AU2003291913A1 (ja)
BR (1) BR0318026A (ja)
CA (1) CA2510482A1 (ja)
CU (1) CU23202A1 (ja)
MX (1) MXPA05008221A (ja)
RU (1) RU2005127340A (ja)
WO (1) WO2004067747A1 (ja)
ZA (1) ZA200505187B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2615372A1 (en) * 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
KR101012830B1 (ko) * 2008-04-25 2011-02-10 메디칸(주) 신규 a형 간염 바이러스의 항원 유전자 및 상기 유전자로형질전환된 식물체

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3484244D1 (de) * 1983-09-30 1991-04-11 Massachusetts Inst Technology Herstellung von cdna die hepatitis a virale sequenzen darstellen.
US5516630A (en) * 1983-09-30 1996-05-14 The United States Of America As Represented By The Department Of Health And Human Services Methods of detecting hepatitis A virus
US4614793A (en) * 1983-10-14 1986-09-30 Merck & Co., Inc. Hepatitis A--subunit antigen
SU1469856A1 (ru) * 1986-07-31 1990-09-30 Институт биоорганической химии им.М.М.Шемякина Способ конструировани рекомбинантной плазмидной ДНК, кодирующей синтез полипептидных субстанций против гепатита А
US5294548A (en) * 1990-04-02 1994-03-15 American Biogenetic Sciences, Inc Recombianant Hepatitis a virus
US5612487A (en) * 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
EP1230257A4 (en) * 1998-12-23 2003-08-13 Thompson Boyce Plant Res EXPRESSION OF IMMUNOGENOUS HEPATITIS B SURFACE ANTIGEN IN TRANSGENIC PLANTS
US6368602B1 (en) * 2000-06-16 2002-04-09 Hadasit Medical Research Services And Development Ltd Mucosal immunization against hepatitis A virus (HAV) through rectal administration of HAV vaccine

Also Published As

Publication number Publication date
CA2510482A1 (en) 2004-08-12
JP2006514078A (ja) 2006-04-27
KR20050100365A (ko) 2005-10-18
US20060147469A1 (en) 2006-07-06
WO2004067747A1 (es) 2004-08-12
BR0318026A (pt) 2005-12-06
ZA200505187B (en) 2006-04-26
AU2003291913A1 (en) 2004-08-23
CN1745174A (zh) 2006-03-08
CU23202A1 (es) 2007-05-18
AR042960A1 (es) 2005-07-13
EP1589111A1 (en) 2005-10-26
RU2005127340A (ru) 2006-03-10

Similar Documents

Publication Publication Date Title
WO2005014806A3 (en) Conserved hbv and hcv sequences useful for gene silencing
WO2004065596A3 (en) Use of the regulatory sequence of the rice gos2 gene for the gene expression in dicotyledonous plants or plant cells
KR970703695A (ko) 식물 바이러스 내성 유전자와 그 제조방법(Plant Virus Resistance Gene and Methods)
AU6871398A (en) Method for enhancing expression of a foreign or endogenous gene product in pla nts
DE69534421D1 (de) Cytoplasmatische Inhibition des Genexpression
ATE160173T1 (de) Potyvirus-hüllproteingene und damit transformierte pflanzen
DK0425004T3 (ja)
EP1098961A4 (en) INTERFERON INDUCING MITIGATED VIRUSES DEVELOPED BY GENETIC ENGINEERING
WO2006069064A3 (en) Conserved hbv and hcv sequences useful for gene silencing
CN107090461A (zh) 一种烟草hkt1基因及其制备方法和应用
WO2006013103A3 (de) Induzierbare genexpression
DE60238309D1 (de) Tomegalovirus genom mit konserviertem wildtyp-charakteristika klinisher isolate enthält
FR2772787B1 (fr) Promoteur h3c4 de mais associe au premier intron de l'actine de riz, gene chimere le comprenant et plante transformee
TR200002909T2 (tr) Rekombinant potivirüs yapısı ve kullanımı
ATE480629T1 (de) Auf cis einwirkende regulierende elemente aus tripsacum-dactyloiden
MXPA05008221A (es) Antigenos recombinantes del virus de la hepatitis a obtenidos en celulas vegetales.
AU7532998A (en) Recombinant construct for enhancement of gene expression in plants
WO2008058752A3 (en) Lentiviral vectors for gene transfer in quiescent (g0) cells
WO2007115385A3 (en) Transfer plasmidic vector and recombinant canarypox virus
JP2002542828A5 (ja)
ES2125842A1 (es) Clones y vectores infectivos de plantas derivados del virus del mosaico del nabo (tumv).
DE60030734T8 (de) Mites-ähnliches element und an trankriptionsaktivierung beteiligtes element
IL139372A (en) Recombinant virus expressing foreign dna encoding feline cd80, feline ctla-4 or feline cd86 and uses thereof
WO2001068863A3 (fr) Sequences polynucleotidiques purifiees de plantes et de levure codant pour des proteines qui interagissent avec les produits du genome des geminivirus
ATE503839T1 (de) Expressionskassetten zur bevorzugten expression in pflanzlichen schliesszellen